-
(-)-JQ1: Definitive Inactive Control for BET Bromodomain ...
2026-01-22
(-)-JQ1 is the gold-standard inactive control for BET bromodomain inhibition in epigenetics and cancer biology research. Unlike its active stereoisomer (+)-JQ1, (-)-JQ1 demonstrates negligible BET binding and is essential for validating target specificity in BRD4-dependent assays.
-
Nicotinamide Riboside Chloride (NIAGEN): Unlocking Precis...
2026-01-21
Discover how Nicotinamide Riboside Chloride, a potent NAD+ metabolism enhancer, is redefining metabolic dysfunction and neurodegenerative disease models. This article uniquely explores its mechanistic role in sirtuin activation and stem cell-derived retinal ganglion cell regeneration.
-
Redefining the Translational Frontier: Mechanistic and St...
2026-01-21
Explore the evolving landscape of CXCR4 chemokine receptor antagonism with Plerixafor (AMD3100). This thought-leadership article offers mechanistic insight into the SDF-1/CXCL12–CXCR4 axis, evaluates recent comparative research in cancer models, and provides strategic recommendations for translational researchers seeking to optimize experimental design and bridge preclinical findings with clinical potential.
-
From Precision Photosynthesis Inhibition to Translational...
2026-01-20
This thought-leadership article examines Diuron (3-(3,4-dichlorophenyl)-1,1-dimethylurea) as a benchmark herbicide research chemical, spotlighting its dual utility in photosystem II inhibition and as a model for environmental nephrotoxicity. Integrating recent mechanistic insights—especially the JAK2/STAT1-mediated acute kidney injury pathway—this piece delivers actionable guidance for translational researchers seeking to leverage high-purity Diuron from APExBIO in advanced plant biology, environmental toxicology, and cross-kingdom toxicodynamics studies.
-
WM-8014: Selective KAT6A/KAT6B Inhibitor for Epigenetic R...
2026-01-20
WM-8014 is a highly selective histone acetyltransferase inhibitor targeting KAT6A and KAT6B. This compound enables precise modulation of oncogene-induced senescence via the p16INK4A–p19ARF pathway, supporting cancer biology and epigenetic drug target research.
455 records 31/31 page Previous First page 上5页 31